Prof. Mangmang Sang, Xiamen Cardiovascular Hospital，Xiamen University, China
Mangmang Sang is a Research Fellow at Xiamen Cardiovascular Hospital, Xiamen University, specializing in biomedical engineering approaches for cancer and cardiovascular disease diagnosis and treatment. She earned her Ph.D. from China Pharmaceutical University and has authored 14 high-impact papers as the primary or corresponding author, accumulating a total impact factor of 138.82 and over 600 citations, with an average of 129 citations per paper. Her research has yielded innovative advancements, including iron-based nanotherapy for multidrug-resistant cancer and the development of micro-nano robot drugs for targeted thrombus and atherosclerosis treatments. Sang has also pioneered fluorescence probe technology for guiding intraoperative imaging, supporting translational research through multiple published and pending patents. Currently, she leads two projects funded by the National Natural Science Foundation of China and the Fujian Provincial Natural Science Foundation.
Professional Profile:
ORCID
Summary of Suitability for Best Researcher Award:
Dr. Mangmang Sang’s impressive portfolio demonstrates a high level of expertise and significant contributions to biomedical engineering, particularly in the diagnosis and treatment of cancer and cardiovascular diseases. With 14 first-author publications in reputable journals and a combined impact factor of 138.82, Dr. Sang’s research has garnered over 600 citations, showcasing the substantial academic and practical impact of her work. Her innovations include advanced diagnostic probes and therapeutic methods, such as “iron death nanotherapy” and “micro-nano robot” drugs, aimed at improving treatment for multidrug-resistant cancers and cardiovascular conditions. Additionally, Dr. Sang has published 4 patents, with another 3 in progress, highlighting her role in the development of transformative medical technologies.
🎓 Academic Background
Dr. Sang earned a Ph.D. from China Pharmaceutical University, specializing in biomedical engineering approaches for cancer and cardiovascular disease diagnosis and treatment. 📚 She has published 14 first-author papers in leading international journals, with a cumulative impact factor of 138.82 🌍 and over 600 citations—7 of these papers boast an impact factor above 10, placing her work in JCR’s top-ranking journals. 🏆 She has filed 7 patents, with 4 already published. 🧬💡
🔬 Research Highlights
Dr. Sang’s innovative work spans iron-based nanotherapy for drug-resistant cancers 💊 and “micro-nano robot” drug delivery systems for targeted thrombosis and atherosclerosis treatments. She has also advanced fluorescence probe diagnostics for tumor and plaque imaging during surgeries, pushing the boundaries of precision medicine. 🦠✨
📑 Research Projects
Currently leading two funded projects (National Natural Science Foundation of China Youth Project, Fujian Provincial Natural Science Foundation), and has successfully completed two others. 🔍📈
💡 Notable Achievements
- Total Impact Factor: 138.82
- Citations: Averaging 129 per paper 📊
- Publications: 19 SCI-indexed articles
- Patents: 4 published, 3 pending
Publication top Notes:
Opportunities and challenges of nano/micro motors in biomedical applications
An “AND” Molecular Logic Gate as a Super‐Enhancers for De Novo Designing Activatable Probe and Its Application in Atherosclerosis Imaging
Peroxynitrite/Lipid Droplet Sequence-Activated Dual-Lock Fluorescent Probes Enable Precise Intraoperative Imaging of Atherosclerotic Plaques
Lipid‐Activatable Fluorescent Probe for Intraoperative Imaging of Atherosclerotic Plaque Using In Situ Patch
Enzyme Catalysis Biomotor Engineering of Neutrophils for Nanodrug Delivery and Cell-Based Thrombolytic Therapy
Controlled “off–on” fluorescent probe for the specific detection of hyperhomocysteinemia
Lipid Droplet-Specific Probe for Rapidly Locating Atherosclerotic Plaques and Intraoperative Imaging via <i>In Situ</i> Spraying